Angeliki Giannelou M.D.

Angeliki Giannelou MD is a seasoned medical professional currently serving as Senior Medical Director at Horizon since April 2023. Prior experience includes a tenure as Medical Director at Regeneron Pharmaceuticals, where Angeliki led clinical programs for drugs such as Sarilumab and was involved in multiple phase 1, 2, and 3 studies for various conditions, including Eosinophilic Esophagitis and COVID-19. Angeliki also held the position of Associate Director in Clinical Sciences at the National Institutes of Health, focusing on autoinflammatory diseases and their genetic underpinnings. With additional expertise gained as an attending rheumatologist and during a fellowship at NIAMS, alongside foundational training in internal medicine and postdoctoral research, Angeliki Giannelou brings a wealth of knowledge and experience in both clinical practice and pharmaceutical development.